Bacterium Clinical Development FDA Approval Regulation 
XTalks
AUGUST 2, 2023
Paxlovid was first authorized under the FDA Emergency Use Authorization in December 2021 ; however, it has received FDA approval on May 25, 2023. pneumoniae serotypes) replaced the company’s first pneumococcal conjugate vaccine Prevnar (PCV7, approved by the FDA in February 2000) in a February 2010 FDA approval.
XTalks
DECEMBER 24, 2020
However, now, test results can be delivered within a day or two thanks to better coordination, ramped up production of test supplies as well as development of rapid tests. Omer maintains that the solution to this challenge is something that’s already in practice by developers of the mRNA vaccines. Vaccine Considerations.
Expert insights. Personalized for you.
98 
Let's personalize your content